We are monitoring the impact of COVID-19 on MEA In-Vitro Toxicology Testing Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 203
Share on
Share on

Middle East and Africa In-Vitro Toxicology Testing Market Research Report – Segmented By Product, Type, Toxicity Endpoints & Tests, Technology, Method, Industry & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) – Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 203
Pages: 145

MEA In-Vitro Toxicology Testing Market Size (2021 to 2026)

The In-vitro toxicology testing market in Middle East & Africa is expected to reach USD 6224.61 Million by 2026 from USD 2288.06 Million in 2021, growing at a CAGR of 22.16% from 2021 to 2026.

In-vitro toxicology testing is the scientific analysis of toxic effects produced by chemical substances on cultured mammalian cells or bacteria. Toxicity testing is essential in drug discovery as it identifies the toxic effects of a new compound in the early stages of drug discovery. This early detection of toxicity reduces the development cost and time.

One of the key drivers boosting the market is significant breakthroughs in toxicity science. In addition, the MEA market for in-vitro toxicity testing is expected to rise due to the high costs connected with traditional animal tests and socio-ethical problems related to animal tests. In-vitro toxicology assays for evaluating drug product safety and assessing the possible effect of medicines on cells and tissues are expected to boost revenue creation in the market. Companies have diversified their portfolios to meet demand in the market for in-vitro toxicology testing, as the demand for such tests has grown. Market stability is projected to be enhanced by significant government support for research combined with clear reimbursement rules to produce automated and technologically advanced equipment for laboratory analysis and ex-vivo testing.

The availability of various tools in the biotechnology and bioinformatics divisions for conducting in-silico simulations on animal models is another key factor, which is expected to accelerate the growth rate of the MEA In-vitro toxicology testing market. Furthermore, the creation of toxicological databases for the in-silico study of various chemicals is expected to increase demand for in-vitro procedures, resulting in industry advancement. Due to an increase in the number of R&D procedures that require in vitro testing, a restriction on animal testing, and increased awareness about environmental concerns, the MEA in vitro toxicity testing market is likely to develop significantly throughout the period. Furthermore, advancements in genetics and genetic screening technologies and the advent of innovative 3D cell culture approaches are expected to increase the in vitro toxicity testing industry. To address the specific criteria of the researchers, large firms have focused on new product launches. Rapid advancements in biomedical sciences are expected to develop newer and more advanced in-vitro test methodologies for hazard characterization. Toxicity testing is gradually improving with the help of many new technologies. It is currently well-positioned to benefit from promising biotechnology revolutions.

However, a lack of immunity testing and immunological stimulation in present in-vitro tests are expected to restrict the market’s growth rate. The existing regulatory guideline for in-vitro toxicity testing does not address specific study designs. In-vitro testing techniques and data documentation should be thorough, repeatable, and include particular analytical methods, as well as documentation of assay procedures and outcomes. As a result, the in-vitro toxicology testing's growth is being hampered by these strict requirements. A lack of understanding of the underlying scientific principles and the proper procedure selection may result in various direct and indirect costs, increasing the workload and time pressure on researchers and service providers. As a result, highly qualified professionals are required for method development, validation, operation, and troubleshooting.

This research report on the Middle East and Africa In-Vitro Toxicology Testing Market has been segmented and sub-segmented into the following categories:

By Product

  • Assays
  • Reagents & Labware
  • Services
  • Growth Hormone Therapy

By Type

  • ADME (Absorption, Distribution, Metabolism, and Excretion)
  • Dose
  • Toxic Substance

By Toxicity Endpoints & Tests

  • Systemic Toxicity
  • Dermal Toxicity
  • Carcinogenicity
  • Ocular Toxicity
  • Skin Sensitization & Irritation
  • Genotoxicity
  • Neurotoxicity
  • Organ Toxicity
  • Other Toxicity Endpoints & Tests

By Technology

  • OMICS Technologies
  • Cell Culture Technology
  • High-Throughput Technologies
  • Molecular Imaging Technologies 

By Method

  • In-Silico Methods
  • Biochemical Assays
  • Cellular Assays
  • Ex-Vivo Models

By Industry

  • Cosmetics and Household Products
  • Diagnostics
  • Pharmaceuticals
  • Food Industry
  • Chemicals

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Increased government focus on drug research, increased healthcare spending, and the provision of suitable infrastructure for drug discovery technology growth and development Furthermore, strict regulatory standards governing medication development and approval have expanded the use of in-vitro toxicology testing services in the Middle East and Africa regional market.

KEY MARKET PLAYERS:

A few of the prominent companies operating in the MEA In-Vitro Toxicology Testing Market profiled in this report are Covance, Inc.  (A subsidiary of LabCorp) (U.S.), Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Eurofins Scientific SE (Luxembourg), General Electric Company (U.S.), BioReliance, Inc. (U.S.), Charles River Laboratories International, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Catalent (U.S.) and Cyprotex (U.K.)

1. Introduction                                                                 

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Product                                        

                                5.1.1 Introduction                                           

                                5.1.2 Assays                                       

                                5.1.3 Reagents & Labware                                           

                                5.1.4 Services     Growth Hormone Therapy                         

                5.2 Type                                              

                                5.2.1 Introduction                                           

                                5.2.2 ADME (Absorption, Distribution, Metabolism, and Excretion)                                          

                                5.2.3 Dose                                          

                                5.2.4 Toxic Substance                                    

                5.3 Toxicity Endpoints & Tests                                   

                                5.3.1 Introduction                                           

                                5.3.2 Systemic Toxicity                                  

                                5.3.3 Dermal Toxicity                                     

                                5.3.4 Carcinogenicity                                      

                                5.3.5 Ocular Toxicity                                       

                                5.3.6 Skin Sensitization & Irritation                                          

                                5.3.7 Genotoxicity                                          

                                5.3.8 Neurotoxicity                                         

                                5.3.9 Organ Toxicity                                        

                                5.3.10 Other Toxicity Endpoints & Tests                                

                5.4 Technology                                 

                                5.4.1 Introduction                                           

                                5.4.2 OMICS Technologies                                           

                                5.4.3 Cell Culture Technology                                     

                                5.4.4 High-Throughput Technologies                                      

                                5.4.5 Molecular Imaging Technologies                                   

                5.5 Method                                       

                                5.5.1 Introduction                                           

                                5.5.2 In-Silico Methods                                 

                                5.5.3 Biochemical Assays                                              

                                5.5.4 Cellular Assays                                       

                                5.5.5 Ex-Vivo Models                                     

                5.6 Industry                                       

                                5.6.1 Introduction                                           

                                5.6.2 Cosmetics and Household Products                                             

                                5.6.3 Diagnostics                                              

                                5.6.4 Pharmaceuticals                                   

                                5.6.5 Food Industry                                        

                                5.6.6 Chemicals                                

6. Geographical Analysis                                                                              

                6.1 Introduction                                                               

                6.2 Middle-East                                                                

                6.3 South Africa                                                               

                6.4 Rest of Middle East & Africa                                                

7. Strategic Analysis                                                                       

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                                                                        

                8.1 Covance, Inc.  (A subsidiary of LabCorp) (U.S.)                                            

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                             

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Agilent Technologies, Inc. (U.S.)                                        

                8.3 Bio-Rad Laboratories, Inc. (U.S.)                                        

                8.4 Eurofins Scientific SE (Luxembourg)                                 

                8.5 General Electric Company (U.S.)                                       

                8.6 BioReliance, Inc. (U.S.)                                      

                8.7 Charles River Laboratories International, Inc. (U.S.)                                  

                8.8 Thermo Fisher Scientific, Inc. (U.S.)                                 

                8.9 Catalent (U.S.)                                          

                8.10 Cyprotex (U.K.)                                      

9. Competitive Landscape                                                                           

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10. Expert Opinions                                                                        

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa In-Vitro Toxicology Testing Market, By Region, From 2021 to 2026 (USD Million)                            
  2. Middle East & Africa In-Vitro Toxicology Testing Market, By Product, From 2021 to 2026 (USD Million)                          
  3. Middle East & Africa Assays Market, By Region, From 2021 to 2026 (USD Million)                    
  4. Middle East & Africa Reagents & Labware Market, By Region, From 2021 to 2026 (USD Million)                        
  5. Middle East & Africa Services Market, By Region, From 2021 to 2026 (USD Million)                 
  6. Middle East & Africa In-Vitro Toxicology Testing Market, By Type, From 2021 to 2026 (USD Million)                
  7. Middle East & Africa ADME (Absorption, Distribution, Metabolism, and Excretion) Market, By Region, From 2021 to 2026 (USD Million)                
  8. Middle East & Africa Dose Market, By Region, From 2021 to 2026 (USD Million)                        
  9. Middle East & Africa Toxic Substance Market, By Region, From 2021 to 2026 (USD Million)                  
  10. Middle East & Africa In-Vitro Toxicology Testing Market, By Toxicity Endpoints & Tests, From 2021 to 2026 (USD Million)                      
  11. Middle East & Africa Systemic Toxicity Market, By Region, From 2021 to 2026 (USD Million)                
  12. Middle East & Africa Dermal Toxicity Market, By Region, From 2021 to 2026 (USD Million)                   
  13. Middle East & Africa Carcinogenicity Market, By Region, From 2021 to 2026 (USD Million)                   
  14. Middle East & Africa Ocular Toxicity Market, By Region, From 2021 to 2026 (USD Million)                     
  15. Middle East & Africa Skin Sensitization & Irritation Market, By Region, From 2021 to 2026 (USD Million)                        
  16. Middle East & Africa Genotoxicity Market, By Region, From 2021 to 2026 (USD Million)                        
  17. Middle East & Africa Neurotoxicity Market, By Region, From 2021 to 2026 (USD Million)                      
  18. Middle East & Africa Organ Toxicity Market, By Region, From 2021 to 2026 (USD Million)                     
  19. Middle East & Africa Other Toxicity Endpoints & Tests Market, By Region, From 2021 to 2026 (USD Million)                
  20. Middle East & Africa In-Vitro Toxicology Testing Market, By Technology, From 2021 to 2026 (USD Million)                   
  21. Middle East & Africa OMICS Technologies Market, By Region, From 2021 to 2026 (USD Million)                        
  22. Middle East & Africa Cell Culture Technology Market, By Region, From 2021 to 2026 (USD Million)                  
  23. Middle East & Africa High-Throughput Technologies Market, By Region, From 2021 to 2026 (USD Million)                    
  24. Middle East & Africa Molecular Imaging Technologies Market, By Region, From 2021 to 2026 (USD Million)                 
  25. Middle East & Africa In-Vitro Toxicology Testing Market, By Method, From 2021 to 2026 (USD Million)                          
  26. Middle East & Africa In-Silico Methods Market, By Region, From 2021 to 2026 (USD Million)                               
  27. Middle East & Africa Biochemical Assays Market, By Region, From 2021 to 2026 (USD Million)                           
  28. Middle East & Africa Cellular Assays Market, By Region, From 2021 to 2026 (USD Million)                    
  29. Middle East & Africa Ex-Vivo Models Market, By Region, From 2021 to 2026 (USD Million)                  
  30. Middle East & Africa In-Vitro Toxicology Testing Market, By Industry, From 2021 to 2026 (USD Million)                         
  31. Middle East & Africa Cosmetics and Household Products Market, By Region, From 2021 to 2026 (USD Million)                           
  32. Middle East & Africa Diagnostics Market, By Region, From 2021 to 2026 (USD Million)                           
  33. Middle East & Africa Pharmaceuticals Market, By Region, From 2021 to 2026 (USD Million)                 
  34. Middle East & Africa Food Industry Market, By Region, From 2021 to 2026 (USD Million)                      
  35. Middle East & Africa Chemicals Market, By Region, From 2021 to 2026 (USD Million)                              
  36. Middle East In-Vitro Toxicology Testing Market, By Product, From 2021 to 2026 (USD Million)                           
  37. Middle East In-Vitro Toxicology Testing Market, By Type, From 2021 to 2026 (USD Million)                 
  38. Middle East In-Vitro Toxicology Testing Market, By Toxicity Endpoints & Tests, From 2021 to 2026 (USD Million)                       
  39. Middle East In-Vitro Toxicology Testing Market, By Technology, From 2021 to 2026 (USD Million)                    
  40. Middle East In-Vitro Toxicology Testing Market, By Method, From 2021 to 2026 (USD Million)                           
  41. Middle East In-Vitro Toxicology Testing Market, By Industry, From 2021 to 2026 (USD Million)                          
  42. South Africa In-Vitro Toxicology Testing Market, By Product, From 2021 to 2026 (USD Million)                          
  43. South Africa In-Vitro Toxicology Testing Market, By Type, From 2021 to 2026 (USD Million)                
  44. South Africa In-Vitro Toxicology Testing Market, By Toxicity Endpoints & Tests, From 2021 to 2026 (USD Million)                      
  45. South Africa In-Vitro Toxicology Testing Market, By Technology, From 2021 to 2026 (USD Million)                   
  46. South Africa In-Vitro Toxicology Testing Market, By Method, From 2021 to 2026 (USD Million)                          
  47. South Africa In-Vitro Toxicology Testing Market, By Industry, From 2021 to 2026 (USD Million)                         
  48. Rest of Middle East & Africa In-Vitro Toxicology Testing Market, By Product, From 2021 to 2026 (USD Million)                           
  49. Rest of Middle East & Africa In-Vitro Toxicology Testing Market, By Type, From 2021 to 2026 (USD Million)                 
  50. Rest of Middle East & Africa In-Vitro Toxicology Testing Market, By Toxicity Endpoints & Tests, From 2021 to 2026 (USD Million)                               
  51. Rest of Middle East & Africa In-Vitro Toxicology Testing Market, By Technology, From 2021 to 2026 (USD Million)                    
  52. Rest of Middle East & Africa In-Vitro Toxicology Testing Market, By Method, From 2021 to 2026 (USD Million)                          
  53. Rest of Middle East & Africa In-Vitro Toxicology Testing Market, By Industry, From 2021 to 2026 (USD Million)                          

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample